Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,552 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Chapter 3: Management of kidney injury caused by cancer drug therapy, from clinical practice guidelines for the management of kidney injury during anticancer drug therapy 2022.
Ando Y, Nishiyama H, Shimodaira H, Takano N, Sakaida E, Matsumoto K, Nakanishi K, Sakai H, Tsukamoto S, Komine K, Yasuda Y, Kato T, Fujiwara Y, Koyama T, Kitamura H, Kuwabara T, Yonezawa A, Okumura Y, Yakushijin K, Nozawa K, Goto H, Matsubara T, Hoshino J, Yanagita M; Committee of Clinical Practice Guidelines for the Management of Kidney Disease During Anticancer Drug Therapy 2022. Ando Y, et al. Among authors: yasuda y. Int J Clin Oncol. 2023 Oct;28(10):1315-1332. doi: 10.1007/s10147-023-02382-2. Epub 2023 Jul 16. Int J Clin Oncol. 2023. PMID: 37453935
Japan Renal Biopsy Registry and Japan Kidney Disease Registry: Committee Report for 2009 and 2010.
Sugiyama H, Yokoyama H, Sato H, Saito T, Kohda Y, Nishi S, Tsuruya K, Kiyomoto H, Iida H, Sasaki T, Higuchi M, Hattori M, Oka K, Kagami S, Kawamura T, Takeda T, Hataya H, Fukasawa Y, Fukatsu A, Morozumi K, Yoshikawa N, Shimizu A, Kitamura H, Yuzawa Y, Matsuo S, Kiyohara Y, Joh K, Nagata M, Taguchi T, Makino H; Committee for Standardization of Renal Pathological Diagnosis; Committee for Kidney Disease Registry; Japanese Society of Nephrology. Sugiyama H, et al. Clin Exp Nephrol. 2013 Apr;17(2):155-73. doi: 10.1007/s10157-012-0746-8. Epub 2013 Feb 6. Clin Exp Nephrol. 2013. PMID: 23385776
Carboplatin dosing for adult Japanese patients.
Ando Y, Shimokata T, Yasuda Y, Hasegawa Y. Ando Y, et al. Among authors: yasuda y. Nagoya J Med Sci. 2014 Feb;76(1-2):1-9. Nagoya J Med Sci. 2014. PMID: 25129986 Free PMC article. Review.
Extension of the Calvert formula to patients with severe renal insufficiency.
Oguri T, Shimokata T, Ito I, Yasuda Y, Sassa N, Nishiyama M, Hamada A, Hasegawa Y, Ando Y. Oguri T, et al. Among authors: yasuda y. Cancer Chemother Pharmacol. 2015 Jul;76(1):53-9. doi: 10.1007/s00280-015-2769-9. Epub 2015 May 10. Cancer Chemother Pharmacol. 2015. PMID: 25957958 Clinical Trial.
Evidence-based clinical practice guidelines for IgA nephropathy 2014.
Yuzawa Y, Yamamoto R, Takahashi K, Katafuchi R, Tomita M, Fujigaki Y, Kitamura H, Goto M, Yasuda T, Sato M, Urushihara M, Kondo S, Kagami S, Yasuda Y, Komatsu H, Takahara M, Harabuchi Y, Kimura K, Matsuo S. Yuzawa Y, et al. Among authors: yasuda y, yasuda t. Clin Exp Nephrol. 2016 Aug;20(4):511-535. doi: 10.1007/s10157-015-1223-y. Clin Exp Nephrol. 2016. PMID: 27095365 Free PMC article. No abstract available.
Obvious Pitfall in the Estimation of Renal Dysfunction.
Shimokata T, Yasuda Y, Ando Y. Shimokata T, et al. Among authors: yasuda y. J Clin Oncol. 2016 Jul 10;34(20):2429. doi: 10.1200/JCO.2015.65.9243. Epub 2016 May 16. J Clin Oncol. 2016. PMID: 27185841 No abstract available.
Guidelines for treatment of renal injury during cancer chemotherapy 2016.
Horie S, Oya M, Nangaku M, Yasuda Y, Komatsu Y, Yanagita M, Kitagawa Y, Kuwano H, Nishiyama H, Ishioka C, Takaishi H, Shimodaira H, Mogi A, Ando Y, Matsumoto K, Kadowaki D, Muto S. Horie S, et al. Among authors: yasuda y. Clin Exp Nephrol. 2018 Feb;22(1):210-244. doi: 10.1007/s10157-017-1448-z. Clin Exp Nephrol. 2018. PMID: 28856465 Free PMC article. Review. No abstract available.
1,552 results